{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02559206","recordId":"NCT02559206","peptideSlug":"linaclotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02559206-linaclotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02559206.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02559206.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-09-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2015-09-22","publishedAt":"2026-08-23","recordId":"NCT02559206","recordSha256":"61533fe6a10793777962bc875b5f0b5839eca5382ff2ddb1a52145dba461c01d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02559206?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-01-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"linaclotide","submittedDate":"2016-01-12","publishedAt":"2026-08-23","recordId":"NCT02559206","recordSha256":"4adb2786397610d25220796ad8cb42d8d21ad30af12985c819c68709e160b3db","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02559206?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-07-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2016-07-22","publishedAt":"2026-08-23","recordId":"NCT02559206","recordSha256":"edbf31712ae0a4d967bab53a896ada42bc9caa4170e22a3c5d2854319e9089b8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02559206?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"linaclotide","submittedDate":"2017-01-19","publishedAt":"2026-08-23","recordId":"NCT02559206","recordSha256":"a76e6331b23f66770e8aadf83f4b141dfd314fcdaa9cb6dbb2706e8ca4a69a59","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02559206?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-04-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"linaclotide","submittedDate":"2020-04-09","publishedAt":"2026-08-23","recordId":"NCT02559206","recordSha256":"85e1afc257942c5e19fb12c805c530b5f9f8f81ba00ed4b69a8655e7f32fdadb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02559206?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"39f1020bd3366bf07f0ff5317f374ce4da97328f2762e2bd286e9ddb206219b1"}}